Clinical Trial Update: Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation [Phase 2]

View source ↗

Summary

Clinical trial update for the SA4Ag vaccine in adults undergoing spinal fusion shows safety and efficacy data from a Phase 2 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcal Infection Prevention

Drugs mentioned

• SA4Ag vaccine

Snippet

Sponsor: Pfizer | Conditions: Staphylococcal Vaccine | Phase 2 | Status: TERMINATED | Results posted: 2020-09-02